|
US4145406A
(en)
|
1977-04-11 |
1979-03-20 |
Miles Laboratories, Inc. |
Specific binding - adsorbent assay method and test means
|
|
US4254082A
(en)
|
1978-06-12 |
1981-03-03 |
Miles Laboratories, Inc. |
Specific binding-adsorbent assay test means
|
|
CA1247538A
(en)
|
1982-05-21 |
1988-12-28 |
Mark C. Glassy |
Human-human hybridomas for solid tumors
|
|
US4687732A
(en)
|
1983-06-10 |
1987-08-18 |
Yale University |
Visualization polymers and their application to diagnostic medicine
|
|
US4690890A
(en)
|
1984-04-04 |
1987-09-01 |
Cetus Corporation |
Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
|
|
JPS60248618A
(ja)
|
1984-05-24 |
1985-12-09 |
Nippon Zoki Pharmaceut Co Ltd |
ジペプチドを含有する潰瘍治療剤
|
|
US4792521A
(en)
|
1985-08-15 |
1988-12-20 |
Immunomedics, Inc. |
Non-enzymatic immunohistochemical staining system and reagents
|
|
US4863875A
(en)
|
1985-08-26 |
1989-09-05 |
Gia Research Company, L.P. |
Dye labelled antibodies as reagents for use in immunoassay systems
|
|
GB8607101D0
(en)
|
1986-03-21 |
1986-04-30 |
Serono Diagnostics Ltd |
Immunoassay
|
|
US5089423A
(en)
|
1987-05-06 |
1992-02-18 |
Cyberfluor Inc. |
Immunoassay methods and reagents and methods for producing the latter
|
|
US5620845A
(en)
|
1988-06-06 |
1997-04-15 |
Ampcor, Inc. |
Immunoassay diagnostic kit
|
|
US5252487A
(en)
|
1989-05-19 |
1993-10-12 |
Cell Analysis Systems, Inc. |
Method and apparatus for determining the amount of oncogene protein product in a cell sample
|
|
US5719063A
(en)
|
1989-08-25 |
1998-02-17 |
Boehringer Mannheim Corporation |
Multiplex immunoassay system
|
|
US6008057A
(en)
|
1989-08-25 |
1999-12-28 |
Roche Diagnostics Corporation |
Immunoassay system
|
|
US5492821A
(en)
|
1990-11-14 |
1996-02-20 |
Cargill, Inc. |
Stabilized polyacrylic saccharide protein conjugates
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
US5280108A
(en)
*
|
1991-09-27 |
1994-01-18 |
United States Of America |
Antibodies to p40
|
|
MD1367C2
(ro)
|
1992-11-13 |
2000-11-30 |
Idec Pharmaceuticals Corporation |
Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom.
|
|
US5482698A
(en)
|
1993-04-22 |
1996-01-09 |
Immunomedics, Inc. |
Detection and therapy of lesions with biotin/avidin polymer conjugates
|
|
US5487975A
(en)
|
1993-11-15 |
1996-01-30 |
Ventana Medical Systems, Inc. |
Biotin/avidin formulation
|
|
CA2182498A1
(en)
|
1994-02-01 |
1995-08-10 |
William J. Larochelle |
Fusion proteins that include antibody and nonantibody portions
|
|
US5869274A
(en)
|
1995-08-09 |
1999-02-09 |
Zymed Laboratories, Inc. |
Immuno-histochemical method that reduces background staining
|
|
US5891658A
(en)
|
1996-06-27 |
1999-04-06 |
FCI--FiberChem, Inc. |
Single-step, solid-state competitive immunoassay
|
|
WO1998007832A1
(en)
|
1996-08-23 |
1998-02-26 |
Ludwig Institute For Cancer Research |
Recombinant vascular endothelial cell growth factor d (vegf-d)
|
|
US7196164B2
(en)
|
1997-07-08 |
2007-03-27 |
Human Genome Sciences, Inc. |
Secreted protein HHTLF25
|
|
ATE417275T1
(de)
|
1997-09-22 |
2008-12-15 |
Novartis Vaccines & Diagnostic |
Puffern zur stabilizierung von hcv antigenen
|
|
US7294459B1
(en)
|
1997-10-15 |
2007-11-13 |
President And Fellows Of Harvard College |
Cell regulatory genes, encoded products, and uses related thereto
|
|
AU3208699A
(en)
|
1998-03-27 |
1999-10-18 |
Johns Hopkins University, The |
P40 protein acts as an oncogene
|
|
JP3524401B2
(ja)
|
1998-09-16 |
2004-05-10 |
株式会社ニチレイ |
酵素抗体複合体およびその製造方法
|
|
ES2228536T3
(es)
|
1999-05-14 |
2005-04-16 |
The Regents Of The University Of California |
Soporte macromolecular a base de dextrano para un farmaco y suministro de un agente de diagnosotico.
|
|
US6723506B2
(en)
|
2000-01-20 |
2004-04-20 |
Brigham And Women's Hospital |
Method of identifying PAX8-PPAR gamma-nucleic acid molecules
|
|
US20030017491A1
(en)
|
2000-09-14 |
2003-01-23 |
Zuo-Rong Shi |
Chromogenic in situ hybridization methods, kits, and compositions
|
|
DE10063179A1
(de)
|
2000-12-18 |
2002-06-20 |
Bayer Ag |
Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US20020173053A1
(en)
|
2001-04-27 |
2002-11-21 |
Bassam Damaj |
Multiple simultaneous antigen detection by immunohistochemistry
|
|
US20040076955A1
(en)
|
2001-07-03 |
2004-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
|
|
US6580056B1
(en)
|
2001-09-21 |
2003-06-17 |
Biocare Medical |
Biological specimen heating device and quality control method for immunohistochemistry heat retrieval procedures
|
|
CA2475356A1
(en)
|
2002-02-12 |
2003-08-21 |
Raven Biotechnologies, Inc. |
Human fetal bladder-derived epithelial cells
|
|
CN1646160A
(zh)
|
2002-03-13 |
2005-07-27 |
拜奥根Idec马萨诸塞公司 |
抗αvβ6抗体
|
|
US7850912B2
(en)
*
|
2003-05-14 |
2010-12-14 |
Dako Denmark A/S |
Method and apparatus for automated pre-treatment and processing of biological samples
|
|
JP4764818B2
(ja)
|
2003-04-11 |
2011-09-07 |
メディミューン，エルエルシー |
組換えｉｌ−９抗体およびその使用
|
|
JP2007501021A
(ja)
|
2003-05-30 |
2007-01-25 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
遺伝子操作された定常領域を含む、抗体および融合タンパク質
|
|
JP4949038B2
(ja)
|
2003-12-01 |
2012-06-06 |
ダコ デンマーク アクティーゼルスカブ |
免疫組織化学的検出のための方法および組成物
|
|
WO2005076005A2
(en)
|
2004-01-30 |
2005-08-18 |
Medizinische Universität Wien |
A method for classifying a tumor cell sample based upon differential expression of at least two genes
|
|
US20050186642A1
(en)
|
2004-02-24 |
2005-08-25 |
Biocare Medical, Inc. |
Immunoassay reagents and methods of use thereof
|
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
|
EP1904531B1
(en)
|
2005-07-08 |
2010-10-06 |
Pfizer Limited |
Madcam antibodies
|
|
JP4736037B2
(ja)
|
2005-10-26 |
2011-07-27 |
株式会社イーベック |
ヒトｇｍ−ｃｓｆに結合するヒトのモノクローナル抗体並びにその抗原結合部分
|
|
PL2289909T3
(pl)
*
|
2005-11-30 |
2015-04-30 |
Abbvie Inc |
Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
|
|
KR101496433B1
(ko)
*
|
2006-06-07 |
2015-02-26 |
바이오얼라이언스 씨.브이. |
암세포 상에서 발현되는 ｃｄ-43 및 ｃｅａ 상의 에피토프를 함유하는 탄수화물을 인식하는 항체 및 이를 이용하는 방법
|
|
AU2007285217B2
(en)
|
2006-08-14 |
2013-02-07 |
Forerunner Pharma Research Co., Ltd |
Diagnosis and treatment of cancer using anti-desmoglein-3 antibodies
|
|
PL2121751T3
(pl)
|
2006-12-08 |
2017-07-31 |
Lexicon Pharmaceuticals, Inc. |
Przeciwciała monoklonalne przeciwko ANGPTL3
|
|
WO2008127642A1
(en)
|
2007-04-11 |
2008-10-23 |
Enteron Limited Partnership |
Myelin specific ige unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis
|
|
JP5117765B2
(ja)
|
2007-05-28 |
2013-01-16 |
国立大学法人 東京大学 |
抗ｒｏｂｏ１抗体を含むｐｅｔ用腫瘍診断剤
|
|
CL2008002856A1
(es)
|
2007-09-26 |
2009-01-16 |
Genentech Inc |
Anticuerpo novedoso (anticuerpo anti-integrina a5b1; mol}ecula de ácido nucleico que lo codifica; vector y célula huesped; método de producción; composición farmacéutica que lo comprende; su uso para inhibir la angiogénesis y/o permeabilidad vascular y cáncer entre otras patologías; y método de detección de la integrina a5b1).
|
|
US8663640B2
(en)
|
2008-08-29 |
2014-03-04 |
Symphogen A/S |
Methods using recombinant anti-epidermal growth factor receptor antibody compositions
|
|
US8927697B2
(en)
|
2008-09-12 |
2015-01-06 |
Isis Innovation Limited |
PD-1 specific antibodies and uses thereof
|
|
US7846762B2
(en)
|
2008-09-22 |
2010-12-07 |
Applied Materials, Inc. |
Integrated emitter formation and passivation
|
|
EP2425253B1
(en)
|
2009-05-01 |
2017-03-22 |
Dako Denmark A/S |
New antibody cocktail
|
|
PE20120475A1
(es)
*
|
2009-05-12 |
2012-05-05 |
Pfizer |
Anticuerpos especificos para dkk-1
|
|
US20120245051A1
(en)
|
2009-10-13 |
2012-09-27 |
Rimm David L |
Objective, quantitative method to predict histological subtype in non-small cell lung cancer
|
|
EP2540827A4
(en)
|
2010-02-26 |
2013-09-04 |
Chugai Pharmaceutical Co Ltd |
ANTI-ICAM3 ANTIBODY AND ITS USE
|
|
EP2402370A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Pierre Fabre Médicament |
Novel antibody for the diagnosis and/or prognosis of cancer
|
|
CA2810016A1
(en)
|
2010-09-03 |
2012-03-08 |
Stem Centrx, Inc. |
Novel modulators and methods of use
|
|
WO2012048154A1
(en)
|
2010-10-06 |
2012-04-12 |
Biocare Medical, Llc |
Methods and systems for efficient processing of biological samples
|
|
US8852592B2
(en)
|
2011-05-10 |
2014-10-07 |
Biocare Medical, Llc |
Systems and methods for anti-PAX8 antibodies
|
|
US9156915B2
(en)
|
2012-04-26 |
2015-10-13 |
Thomas Jefferson University |
Anti-GCC antibody molecules
|
|
US9429577B2
(en)
|
2012-09-27 |
2016-08-30 |
Biocare Medical, Llc |
Anti-uroplakin II antibodies systems and methods
|
|
US10429390B2
(en)
*
|
2012-12-18 |
2019-10-01 |
Biocare Medical, Llc |
Antibody cocktail systems and methods for classification of histologic subtypes in lung cancer
|
|
EP2962113B1
(en)
|
2013-02-28 |
2019-04-03 |
Biocare Medical, LLC |
Anti-p40 antibodies systems and methods
|
|
WO2015051320A2
(en)
|
2013-10-03 |
2015-04-09 |
Biocare Medical, Llc |
Anti-sox10 antibody systems and methods
|